ADMA Biologics Inc – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ADMA
Share price (9/11/26): $9.23
Market cap (9/11/26): $2.067 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 266 pages Master Purchase and Sale Agreement by and Among Biotest Pharmaceuticals Corporation, Adma Biomanufacturing, LLC, Adma Biologics, Inc., and Solely for the Purposes of Sections 6.7, 8.13, 8.14 and Article XII, Biotest AG and Biotest US Corporation Dated as of January 21, 2017

from 8-K 6 pages Plan of reorganization, merger, acquisition or similar

from 8-K 44 pages Agreement and Plan of Merger by and Among R&R Acquisition VI, Inc., Adma Biologics, Inc. and Adma Acquisition Sub, Inc